Unknown

Dataset Information

0

Identification of an 8-miRNA signature as a potential prognostic biomarker for glioma


ABSTRACT: Background Glioma is the most common form of primary malignant intracranial tumor. Methods In the current study, miRNA matrix were obtained from the Chinese Glioma Genome Atlas (CGGA), and then univariate Cox regression analysis and Lasso regression analysis were utilized to select candidate miRNAs and multivariate Cox regression analysis was applied to establish a miRNA signature for predicting overall survival (OS) of glioma. The signature was assessed with the area under the curve (AUC) of the receiver operating characteristic curve (ROC) and validated by data from Gene Expression Omnibus (GEO). Results Eight miRNAs (miR-1246, miR-148a, miR-150, miR-196a, miR-338-3p, miR-342-5p, miR-548h and miR-645) were included in the miRNA signature. The AUC of ROC analysis for 1- and 3-year OS in the CGGA dataset was 0.747 and 0.905, respectively. In the GEO dataset, The AUC for 1- and 3-year was 0.736 and 0.809, respectively. The AUC in both the CGGA and GEO datasets was similar to that based on WHO 2007 classification (0.736 and 0.799) and WHO 2016 classification (0.663 and 0.807). Additionally, Kaplan–Meier plot revealed that high-risk score patients had a poorer clinical outcome. Multivariate Cox regression analysis suggested that the miRNA signature was an independent prognosis-related factor [HR: 6.579, 95% CI [1.227?35.268], p = 0.028]. Conclusion On the whole, in the present study, based on eight miRNAs, a novel prognostic signature was developed for predicting the 1- and 3- year survival rate in glioma. The results may be conducive to predict the precise prognosis of glioma and to elucidate the underlying molecular mechanisms. However, further experimental researches of miRNAs are needed to validate the findings of this study.

SUBMITTER: Ji B 

PROVIDER: S-EPMC7528815 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7060510 | BioStudies
1000-01-01 | S-EPMC6125451 | BioStudies
2020-01-01 | S-EPMC7772397 | BioStudies
2018-01-01 | S-EPMC6279316 | BioStudies
1000-01-01 | S-EPMC5528529 | BioStudies
2020-01-01 | S-EPMC7392022 | BioStudies
1000-01-01 | S-EPMC5053720 | BioStudies
2018-01-01 | S-EPMC5927061 | BioStudies
2011-01-01 | S-EPMC3126851 | BioStudies
2019-01-01 | S-EPMC6814066 | BioStudies